Market Overview

Patheon to Invest $45 Million, Expanding Capabilities to Support Continued Growth


N.V. (NYSE:PTHN), a leading global provider of high-quality drug
development and delivery solutions to the pharmaceutical sector, today
announced that it expects to invest approximately $45 million at key
sites across its global network to meet growing customer demand for
expanded service capabilities.

"As outsourcing of Pharma development and manufacturing services
continues to grow, our customers will need even more advanced
technologies and customized solutions to meet their business needs,"
said Michel Lagarde, president of Patheon. "With the increasing
marketplace pressures, pharma companies are looking to build more
reliable, flexible and cost-efficient supply chains. With our focus on
people, process and capabilities, Patheon is uniquely positioned to
partner with pharma companies to achieve their objectives – cost
effectively while delivering the highest quality."

Patheon is investing in the following key areas:

Commercial & Development Spray Drying
The company's
recently acquired site located in Florence, South Carolina, will be
adding commercial spray drying capabilities, complementing the existing
development capabilities available at the company's low-solubility
center of excellence in Bend, Oregon. The 15,000-sq.-ft. dedicated suite
will contain two spray dryers delivering development and commercial
scale spray-dried dispersion (SDD) services. The suite is expected to be
online in 2019. Spray Drying is a process that creates amorphous solid
dispersions and is a key technology utilized to enhance the solubility
of poorly soluble drugs.

At the Bend, Oregon site the company plans to expand existing
development SDD capabilities with a new cGMP analytical lab,
manufacturing suite and additional development scale spray drying.
Together, the expertise and capabilities at the Florence and Bend
locations provide clients with an end-to-end solution for products with
solubility challenges, from development to commercialization, to
successfully bring products to market.

Flexible Manufacturing Solutions
Patheon has invested in a
new commercial sterile product manufacturing facility in its Monza,
Italy site. The facility will house three, 40 sq M lyophilizers with
associated eight-headed integrated filling equipment for both lyo and
liquid formulations for small and large molecules in a range of vial
specifications. The equipment will have full CIP/SIP systems, auto
loading for the lyophilizers contained in full RABs systems to ensure
the highest level of sterility assurance.

Patheon also plans to expand its sterile product Pharmaceutical
Development Services (PDS) at the Monza facility. The sterile suite will
contain two 7m2 lyophilizers and associated sterile vial
filling line and analytical laboratory. This new facility will serve the
company's clients seeking to develop both small and large molecule
injectable products (liquid and lyo formulations) and will be
operational in mid-2019. All of Patheon's PDS sterile suites are
co-located within facilities with commercial scale capabilities to ease
with the transition from clinical to commercialization.

Patheon will also expand its packaging and serialization capabilities at
its Greenville, NC site. The company has built a new filling and
packaging suite and upgraded another of its packaging lines with new
technology to improve efficiency and reduce change-over time. The newly
constructed 4,800-square-foot suite will come online this fall and
features a filling and packaging line equipped with an Optel
serialization system. The state-of-the-art system includes cameras,
pharma proof stations, line master, and bottle and bundle tracker

These investments will help clients realize greater efficiency and
accelerate the delivery of products to market.

About Patheon
Patheon is a leading global provider of
pharmaceutical development and manufacturing services. With
approximately 9,100 employees and contractors worldwide, Patheon
provides a comprehensive, integrated and highly customizable set of
solutions to help clients of all sizes satisfy complex development and
manufacturing needs at any stage of the pharmaceutical development
cycle. A Healthier World. Delivered.

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at